Experimental Evaluation of the Hypersensitivity Reactions of a New Glycopeptide Antibiotic Flavancin in Animal Models
Glycopeptide antibiotics are still in demand in clinical practice for treating infections caused by resistant gram-positive pathogens; however, their use is limited due to severe adverse reactions. Their predominant types of side effects are immunoglobulin E-mediated or nonmediated hypersensitivity...
Main Authors: | Michael I. Treshchalin, Vasilisa A. Polozkova, Elena I. Moiseenko, Andrey E. Shchekotikhin, Svetlana A. Dovzhenko, Mikhail B. Kobrin, Eleonora R. Pereverzeva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/11/1569 |
Similar Items
-
Evaluation of Toxic Properties of New Glycopeptide Flavancin on Rats
by: Michael I. Treshchalin, et al.
Published: (2022-05-01) -
Evaluation of errors during susceptibility reporting of glycopeptide antibiotics for enterococcal isolates on sole basis of widely used disk diffusion test
by: Vikas Saini, et al.
Published: (2022-12-01) -
Glycopeptide Hypersensitivity and Adverse Reactions
by: Vanthida Huang, et al.
Published: (2020-04-01) -
First Characterization of a Cluster of VanA-Type Glycopeptide-Resistant Enterococcus faecium, Colombia
by: Diana Panesso, et al.
Published: (2002-09-01) -
Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete
by: Andy Hesketh, et al.
Published: (2021-02-01)